<p>eXoZymes Inc. (NASDAQ:EXOZ - 获取免费报告) 的股价在周二上涨了 5.5%。该股交易最高达到 11.25 美元，最后交易价格为 11.25 美元。在交易中，共成交 3,006 股，较平均交易量 3,609 股下降了 17%。该股此前收盘价为 10.66 美元。</p>
<h2>分析师评级变动</h2>
<p>另外，Weiss Ratings 在 12 月 29 日的报告中重申了对 eXoZymes 股票的 &#34;卖出 (d-)&#34; 评级。一位股票研究分析师对该股给予了卖出评级，根据 MarketBeat 的数据，eXoZymes 的平均评级为 &#34;卖出&#34;。</p>
<p><strong>获取我们对 EXOZ 的最新分析</strong></p>
<h2>eXoZymes 价格表现</h2>
<p>该公司的速动比率为 4.53，流动比率为 4.53，债务股本比率为 0.01。该股的 50 日移动平均价格为 12.21 美元，200 日移动平均价格为 12.26 美元。该公司的市值为 9,450 万美元，市盈率为 -14.61，贝塔值为 2.36。</p>
<p>eXoZymes (NASDAQ:EXOZ - 获取免费报告) 最近在 11 月 13 日发布了季度财报。该公司报告每股收益 (EPS) 为 -0.27 美元。</p>
<h2>关于 eXoZymes</h2>
<p>(获取免费报告)</p>
<p>eXoZymes, Inc 开发、制造和供应一系列用于分子生物学研究和诊断应用的酶和试剂。该公司的酶工程平台支撑着一系列旨在支持核酸纯化、扩增和分析工作流程的产品组合。</p>
<p>eXoZymes 的主要产品包括基于磁珠的核酸提取试剂盒、DNA 聚合酶、逆转录酶、蛋白酶和定制酶服务。此外，该公司还提供用于病原体检测的分子诊断测试试剂盒，利用可扩展的生产流程和符合监管标准的质量体系。</p>
<p>eXoZymes 为全球的学术研究机构、生物技术和制药公司以及临床诊断实验室提供服务。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 eXoZymes 更好</li>
<li>你的银行账户不再安全</li>
<li>Ray Dalio 说买黄金。我说每月从中获利</li>
<li>每天一次一小时</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>他们刚刚试图杀死黄金</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 eXoZymes 吗？</h2>
<p>在你考虑 eXoZymes 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买... 而 eXoZymes 并不在名单上。</p>
<p>虽然 eXoZymes 目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

EXOZ

<p>eXoZymes (NASDAQ:EXOZ) 的股价上涨了 5.5%，达到 11.25 美元，尽管交易量较平均水平下降了 17%。分析师维持 “卖出” 评级，Weiss Ratings 重申 “卖出 (d-)” 评级。该公司报告的季度每股收益为（$0.27），市值为 9450 万美元。eXoZymes 专注于分子生物学和诊断应用的酶和试剂开发，服务于各种研究和临床领域</p>

<p>eXoZymes Inc. (NASDAQ:EXOZ - Get Free Report)'s stock price shot up 5.5% on Tuesday . The stock traded as high as $11.25 and last traded at $11.25. 3,006 shares changed hands during trading, a decline of 17% from the average session volume of 3,609 shares. The stock had previously closed at $10.66.</p>
<div class="lb-trans"><p>eXoZymes Inc. (NASDAQ:EXOZ - 获取免费报告) 的股价在周二上涨了 5.5%。该股交易最高达到 11.25 美元，最后交易价格为 11.25 美元。在交易中，共成交 3,006 股，较平均交易量 3,609 股下降了 17%。该股此前收盘价为 10.66 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Separately, Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of eXoZymes in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, eXoZymes has an average rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 12 月 29 日的报告中重申了对 eXoZymes 股票的 &#34;卖出 (d-)&#34; 评级。一位股票研究分析师对该股给予了卖出评级，根据 MarketBeat 的数据，eXoZymes 的平均评级为 &#34;卖出&#34;。</p>
</div><p><strong>Get Our Latest Analysis on EXOZ</strong></p>
<div class="lb-trans"><p><strong>获取我们对 EXOZ 的最新分析</strong></p>
</div><h2>eXoZymes Price Performance</h2>
<div class="lb-trans"><h2>eXoZymes 价格表现</h2>
</div><p>The company has a quick ratio of 4.53, a current ratio of 4.53 and a debt-to-equity ratio of 0.01. The stock's 50-day moving average price is $12.21 and its 200 day moving average price is $12.26. The firm has a market cap of $94.50 million, a price-to-earnings ratio of -14.61 and a beta of 2.36.</p>
<div class="lb-trans"><p>该公司的速动比率为 4.53，流动比率为 4.53，债务股本比率为 0.01。该股的 50 日移动平均价格为 12.21 美元，200 日移动平均价格为 12.26 美元。该公司的市值为 9,450 万美元，市盈率为 -14.61，贝塔值为 2.36。</p>
</div><p>eXoZymes (NASDAQ:EXOZ - Get Free Report) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($0.27) earnings per share (EPS) for the quarter.</p>
<div class="lb-trans"><p>eXoZymes (NASDAQ:EXOZ - 获取免费报告) 最近在 11 月 13 日发布了季度财报。该公司报告每股收益 (EPS) 为 -0.27 美元。</p>
</div><h2>About eXoZymes</h2>
<div class="lb-trans"><h2>关于 eXoZymes</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>eXoZymes, Inc develops, manufactures and supplies a range of enzymes and reagents designed for molecular biology research and diagnostic applications. The company's enzyme engineering platform underpins a portfolio of products aimed at supporting nucleic acid purification, amplification and analysis workflows.</p>
<div class="lb-trans"><p>eXoZymes, Inc 开发、制造和供应一系列用于分子生物学研究和诊断应用的酶和试剂。该公司的酶工程平台支撑着一系列旨在支持核酸纯化、扩增和分析工作流程的产品组合。</p>
</div><p>Key offerings from eXoZymes include magnetic bead–based nucleic acid extraction kits, DNA polymerases, reverse transcriptases, proteases and custom enzyme services. In addition, the company provides molecular diagnostic test kits designed for pathogen detection, leveraging scalable production processes and quality systems aligned with regulatory standards.</p>
<div class="lb-trans"><p>eXoZymes 的主要产品包括基于磁珠的核酸提取试剂盒、DNA 聚合酶、逆转录酶、蛋白酶和定制酶服务。此外，该公司还提供用于病原体检测的分子诊断测试试剂盒，利用可扩展的生产流程和符合监管标准的质量体系。</p>
</div><p>eXoZymes serves academic research institutions, biotechnology and pharmaceutical companies, and clinical diagnostic laboratories worldwide.</p>
<div class="lb-trans"><p>eXoZymes 为全球的学术研究机构、生物技术和制药公司以及临床诊断实验室提供服务。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than eXoZymes</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It</li>
<li>1 Hour Once A Day</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>They just tried to kill gold</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 eXoZymes 更好</li>
<li>你的银行账户不再安全</li>
<li>Ray Dalio 说买黄金。我说每月从中获利</li>
<li>每天一次一小时</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>他们刚刚试图杀死黄金</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in eXoZymes Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 eXoZymes 吗？</h2>
</div><p>Before you consider eXoZymes, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 eXoZymes 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eXoZymes wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买... 而 eXoZymes 并不在名单上。</p>
</div><p>While eXoZymes currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 eXoZymes 目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

eXoZymes（NASDAQ:EXOZ）股价上涨 5.5% - 以下是原因